
A new drug thought to slow the progression of womb cancer is being made available to some patients treated by the NHS.
Marketed under the brand Jemperli, the medical community believes the drug can improve the life expectancy of women suffering from womb cancer. Up to 200 women may be eligible to receive the drug each year after the NHS began to make it available in UK hospitals this week.